drugset / Trial / NCT07046715
Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State
RandomizedCrossoverOpen-labelTreatment
Summary
This study is to compare pharmacokinetics and safety profiles of single-administration of DA-5222 and co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in healthy adult subjects in fed state
Timeline
- Start
- 2025-07-07
- Primary completion
- 2025-08-19
- Completion
- 2025-08-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | DA-5222 | Unknown | — | — |
| Subject | DA-5222-R1 | Unknown | — | — |
| Subject | DA-5222-R2 | Unknown | — | — |
| Subject | DA-5222-R3 | Unknown | — | — |
Indications
No indication recorded.